Signal detail

SLS SELLAS Life Sciences Group, Inc.

Updated 7:27 AMMarket data as of Jul 10, 2026

Watch / NeutralEvidence coverage: HighHorizon: 20 trading days

Fresh context exists, but no clean directional setup is confirmed.

Main positive: No clear positive driver
Main negative: No clear negative blocker
Watch next: Estimate stabilization

Community discussion, filings & events →

Price-model views unavailable in this refresh. Price-model filters are disabled until the next matching artifact publishes.

Price Model / Risk

Why this model viewPrice call unavailable.

Key levelNo call — evidence only

Model thesisAwait latest price-call artifact.

Benchmarkn/a

Signal supportNo matching price-call artifact row.

Returns

5D10D20D

Stockn/an/an/a

Benchmarkn/an/an/a

Relativen/a

Price levels

Closen/a

Pullback lown/a

Supportn/a

Resistancen/a

SMA20n/a

SMA50n/a

Drivers

None

Warnings

None

Research / Monitor

Quality context

D quality

Quality data supports research context and still needs signal confirmation.

Analyst / Fundamentals

FundamentalsFundamentals unavailable

Analyst coverage1 analysts / tight targets

FlagsAnalyst covered + Tight targets

Monitor

WatchEstimate stabilization

Newsmarkets

HistoryNo measured history yet

Freshness

Fundamentals week2026-W28

Analyst dateJul 10, 2026

Price-model track record

SLS’s past model calls

This symbol’s completed bullish and bearish model views from the last 120 trading days, measured against their assigned benchmark after next trading-day entry.

Updated Jul 10, 2026

SIGNAL DATE	SYMBOL	MODEL VIEW	ENTRY DATE	ENTRY CLOSE	5D VS BENCH	10D VS BENCH	20D VS BENCH	STATUS
Jun 29, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 30, 2026	$14.76	Worked — lagged IWM by 4.5 pts	Pending	Pending	5D measured
Jun 26, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 29, 2026	$15.45	Worked — lagged IWM by 11.7 pts	Pending	Pending	5D measured
Jun 17, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 18, 2026	$8.05	Missed — beat IWM by 52.5 pts	Missed — beat IWM by 72.0 pts	Pending	10D measured
Jun 9, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 10, 2026	$7.15	Missed — beat IWM by 5.8 pts	Missed — beat IWM by 41.3 pts	Pending	10D measured
Jun 8, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 9, 2026	$7.68	Worked — lagged IWM by 3.0 pts	Missed — beat IWM by 16.7 pts	Pending	10D measured
Jun 5, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 8, 2026	$7.98	Worked — lagged IWM by 6.8 pts	Missed — beat IWM by 10.2 pts	Missed — beat IWM by 69.1 pts	Matured
Jun 4, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 5, 2026	$8.23	Worked — lagged IWM by 7.1 pts	Worked — lagged IWM by 0.4 pts	Missed — beat IWM by 60.6 pts	Matured
Jun 3, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 4, 2026	$9.04	Worked — lagged IWM by 13.7 pts	Worked — lagged IWM by 12.2 pts	Missed — beat IWM by 51.8 pts	Matured
Jun 2, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 3, 2026	$8.19	Worked — lagged IWM by 10.5 pts	Worked — lagged IWM by 5.8 pts	Missed — beat IWM by 79.7 pts	Matured
Jun 1, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	Jun 2, 2026	$8.33	Worked — lagged IWM by 6.9 pts	Worked — lagged IWM by 9.7 pts	Missed — beat IWM by 56.7 pts	Matured
May 28, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	May 29, 2026	$9.31	Worked — lagged IWM by 10.2 pts	Worked — lagged IWM by 16.8 pts	Missed — beat IWM by 63.0 pts	Matured
May 27, 2026	SLS SELLAS Life Sciences Group, Inc.	Bearish View	May 28, 2026	$9.18	Worked — lagged IWM by 1.5 pts	Worked — lagged IWM by 15.0 pts	Missed — beat IWM by 32.3 pts	Matured

Evidence

Signal rows

Evidence	Signal	Strength	What changed	Impact
	Neutral	Medium	Current estimates have no directional weekly revision	Monitor only
Why this matters Estimate revisions show whether earnings and revenue expectations are moving in a helpful or harmful direction. MarketMind interpretation Current estimates have no directional weekly revision MarketMind currently classifies SLS as Watch / Neutral. Source detail EPS revision 0.0% Revenue revision 0.0% EPS analysts 1 Revenue analysts 1 Date Jul 10, 2026
	Neutral	Low	No threshold-level insider activity in the current window	Monitor only
Why this matters Insider activity can flag whether company insiders are buying into the setup or selling into strength. MarketMind interpretation No threshold-level insider activity in the current window MarketMind currently classifies SLS as Watch / Neutral. Source detail Net insider value $0 Buy count 0 Sell count 0
	Neutral	Low	No directional technical confirmation	Monitor only
Why this matters Technical action shows whether price and volume confirm the setup or create timing risk. MarketMind interpretation No directional technical confirmation MarketMind currently classifies SLS as Watch / Neutral. Source detail 1d return -5.5% 20d return +63.0% Gap -1.8% Date Jul 10, 2026
	Context	Low	Earnings expected in 32 calendar days	Monitor only
Why this matters Earnings reaction shows whether the market rewarded or rejected the most recent company update. MarketMind interpretation Earnings expected in 32 calendar days MarketMind currently classifies SLS as Watch / Neutral. Source detail Earnings date Aug 11, 2026 Reaction -5.5%
	Neutral	Medium	Current consensus target has no directional weekly change	Monitor only
Why this matters Price targets show whether analyst valuation expectations support or resist the current stock price. MarketMind interpretation Current consensus target has no directional weekly change MarketMind currently classifies SLS as Watch / Neutral. Source detail Target change 0.0% Upside -78.1% Analysts 0 Consensus target $2.80 Date Jul 10, 2026
	Context	Low	No analyst action in current artifact	Monitor only
Why this matters Analyst rating changes can show whether professional expectations are improving or deteriorating. MarketMind interpretation No analyst action in current artifact MarketMind currently classifies SLS as Watch / Neutral. Source detail Source detail No source metric supplied
	Context	Low	markets	Monitor only
Why this matters News context explains whether current headlines are active enough to monitor, without treating raw coverage as a directional signal. MarketMind interpretation active news context MarketMind currently classifies SLS as Watch / Neutral. Source detail Source Benzinga Category markets Tier 1 Date Jul 8, 2026

Method & data

How each setup is built

Each row starts with rules-based signal detection, then checks which evidence lanes are active, whether price action and benchmark context pass the current rule gates, and what level would confirm or invalidate the setup.

Price-model views return after the next matching artifact refreshes.Evidence: shows which bullish and bearish rule inputs are active.Price model: positive and neutral views come from long-entry gates; exit watch and negative views come from extension plus technical weakening.Price action: 5D/10D/20D shows benchmark-relative movement into the latest close, not a completed result.Expanded details show the raw stock move, benchmark move, and relative spread.Confirm / break: the level that would validate or invalidate the setup.Outcomes: completed price-model views appear separately after the measurement window matures.

	SYMBOL	SETUP	SIGNAL CLOSE	EVIDENCE SUPPORT	TOP FACTORS	RULE CONF.	5D	10D	20D	VS BENCH	CONFIRM / BREAK	WHY	DETAILS

Signals

Explore

SLS SELLAS Life Sciences Group, Inc.

SLS’s past model calls

Signal rows

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail